课题基金 / 基金详情

DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED PARALLEL GROUP MULTICENTER STUDY

DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED PARALLEL GROUP MULTICENTER STUDY
双盲随机安慰剂对照平行组多中心研究
批准号：
6291116
负责人：
C. CONRAD JOHNSTON
金额：
$0.04万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6291116
关键词：
bone density bone metabolism calcium metabolism clinical research clinical trials drug adverse effect drug screening /evaluation human subject human therapy evaluation physiologic bone resorption placebos skeletal disorder chemotherapy

项目摘要

项目成果

C. CONRAD JOHNSTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A Double-blind, randomized, placebo-controlled, parallel-group study to evaluate the safety and effect on bone density and bone and calcium biochemistry. Patients will be blocked in groups of 5, with one subject at each of the three dose levels and two subjects receiving placebo in each block.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF SEX STEROIDS IN AGE-RELATED BONE LOSS
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
海外基金